Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
11.78
+0.15 (1.29%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $735.74 million as of July 24, 2026. Its market cap has increased by 203.52% in one year.
Market Cap
735.74M
Enterprise Value
515.65M
1-Year Change
203.52%
Ranking
Category
Stock Price
$11.78
ChartMarket Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $735.74M, a decrease of -66.65%. That is a compound annual growth rate of -18.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 735.74M | 37.70% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 770.86M |
| Tenax Therapeutics | 742.36M |
| Monopar Therapeutics | 735.99M |
| Climb Bio | 735.23M |
| Aclaris Therapeutics | 730.44M |
| Faeth Therapeutics | 729.28M |
| Omeros | 708.55M |
| BridgeBio Oncology Therapeutics | 706.54M |